Δ
Race Oncology’s Mr Phil Lynch (CEO & MD) and Dr Daniel Tillett (CSO & ED) presented to the MST Access Australian Micro & Small Caps Conference 2021 on the 17th June 2021.
https://youtu.be/BiM2feiwPs0
MST Access has initiated coverage of Race Oncology with a current $4.88 per share valuation.…
Race Oncology Limited (ASX: RAC) (Race) is pleased to release an updatedinvestor presentation and invite…